Company intelligence / Profile preview

Dutch Ophthalmic Research Center

Zuidland, South Holland, Netherlandsdorcglobal.com ↗

Ownership: Private
Employees: ~800
Development stage: Commercial

Overview

DORC has over four decades of experience as a global leader in innovative ophthalmic surgical equipment, exporting to more than eighty countries with direct sales in fifteen markets. The company’s solutions are widely adopted by surgeons worldwide and have contributed significantly to advances in vitreoretinal and combined eye surgeries. In April 2024, it was acquired by Carl Zeiss Meditec AG to further expand its reach and innovation pipeline.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

No specific major pharma/biotech partnerships disclosed; close collaborations with leading eye surgeons globally for R&D/product development.

Beyond the preview

Go deeper on Dutch Ophthalmic Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dutch Ophthalmic Research Center.

Explore the full profile